Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1989 Feb;96(2):480–494. doi: 10.1111/j.1476-5381.1989.tb11841.x

The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: a voltage clamp study on neuronal cells in culture.

R F Halliwell 1, J A Peters 1, J J Lambert 1
PMCID: PMC1854359  PMID: 2647206

Abstract

1. Some possible molecular mechanisms of action of the anxiolytic, anticonvulsant and neuroprotective agent MK-801 have been examined in 'whole-cell' voltage clamp recordings performed on rat hippocampal and cortical neurones, bovine adrenomedullary chromaffin cells and N1E-115 neuroblastoma cells maintained in cell culture. 2. Transmembrane currents recorded from rat hippocampal and cortical neurones in response to locally applied N-methyl-D-aspartate (NMDA) were antagonized by MK-801 (0.1-3.0 microM). Blockade was use-dependent, and little influenced by transmembrane potential. MK-801 (3 microM) had no effect on currents evoked by kainate (100 microM). 3. The antagonism of NMDA-induced currents by MK-801 was only slowly and incompletely reversed when the cell membrane potential was clamped at -60 mV during washout. Prolonged applications of NMDA at +40, but not -60 mV during washout, markedly accelerated recovery from block. 4. In contrast to MK-801, ketamine (10 microM) blocked NMDA-induced currents in a voltage-dependent manner. Blockade increased with membrane hyperpolarization and was completely reversible upon washout. 5. MK-801 (1-10 microM) produced a voltage- and concentration-dependent block of membrane currents elicited by ionophoretically applied acetylcholine (ACh) recorded from bovine chromaffin cells. The block was readily reversible upon washout. 6. gamma-Aminobutyric acidA (GABAA) receptor-mediated chloride currents of chromaffin cells were unaffected by MK-801 (1-100 microM). In contrast, such currents were potentiated by diazepam (1 microM). MK-801 (100 microM) had no effect on currents evoked by GABA on hippocampal neurones. 7. MK-801 (10 microM) had little effect on membrane currents recorded from N1E-115 neuroblastoma cells in response to ionophoretically applied 5-hydroxytryptamine (5-HT). Such currents were antagonized by the 5-HT3 receptor antagonist GR 38032F (1 nM) and also by MK-801 at high concentration (100 microM). 8. Voltage-activated, tetrodotoxin-sensitive, sodium currents of chromaffin cells were unaffected by 10 microM MK-801. However, at a relatively high concentration (100 microM), MK-801 reduced the amplitude of such currents to approximately 77% of control. 9. The relevance of the present results to the central actions of MK-801 is discussed.

Full text

PDF
480

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aguayo L. G., Albuquerque E. X. Blockade and recovery of the acetylcholine receptor produced by a thienyl analog of phencyclidine: influence of voltage, temperature, frequency of stimulation and conditioning pulse duration. J Pharmacol Exp Ther. 1986 Oct;239(1):25–31. [PubMed] [Google Scholar]
  2. Anis N. A., Berry S. C., Burton N. R., Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol. 1983 Jun;79(2):565–575. doi: 10.1111/j.1476-5381.1983.tb11031.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bormann J., Clapham D. E. gamma-Aminobutyric acid receptor channels in adrenal chromaffin cells: a patch-clamp study. Proc Natl Acad Sci U S A. 1985 Apr;82(7):2168–2172. doi: 10.1073/pnas.82.7.2168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bowery N. G., Wong E. H., Hudson A. L. Quantitative autoradiography of [3H]-MK-801 binding sites in mammalian brain. Br J Pharmacol. 1988 Apr;93(4):944–954. doi: 10.1111/j.1476-5381.1988.tb11484.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Butler A., Hill J. M., Ireland S. J., Jordan C. C., Tyers M. B. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol. 1988 Jun;94(2):397–412. doi: 10.1111/j.1476-5381.1988.tb11542.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Changeux J. P., Pinset C., Ribera A. B. Effects of chlorpromazine and phencyclidine on mouse C2 acetylcholine receptor kinetics. J Physiol. 1986 Sep;378:497–513. doi: 10.1113/jphysiol.1986.sp016232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Childs A. M., Evans R. H., Watkins J. C. The pharmacological selectivity of three NMDA antagonists. Eur J Pharmacol. 1988 Jan 5;145(1):81–86. doi: 10.1016/0014-2999(88)90352-4. [DOI] [PubMed] [Google Scholar]
  8. Clineschmidt B. V. Effect of the benzodiazepine receptor antagonist Ro 15-1788 on the anticonvulsant and anticonflict actions of MK-801. Eur J Pharmacol. 1982 Oct 15;84(1-2):119–121. doi: 10.1016/0014-2999(82)90167-4. [DOI] [PubMed] [Google Scholar]
  9. Cottrell G. A., Lambert J. J., Peters J. A. Modulation of GABAA receptor activity by alphaxalone. Br J Pharmacol. 1987 Mar;90(3):491–500. doi: 10.1111/j.1476-5381.1987.tb11198.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Davies S. N., Martin D., Millar J. D., Aram J. A., Church J., Lodge D. Differences in results from in vivo and in vitro studies on the use-dependency of N-methylaspartate antagonism by MK-801 and other phencyclidine receptor ligands. Eur J Pharmacol. 1988 Jan 12;145(2):141–151. doi: 10.1016/0014-2999(88)90225-7. [DOI] [PubMed] [Google Scholar]
  11. Dreyer F., Peper K. Iontophoretic application of acetylcholine: advantages of high resistance micropipettes in connection with an electronic current pump. Pflugers Arch. 1974 Apr 22;348(3):263–272. doi: 10.1007/BF00587417. [DOI] [PubMed] [Google Scholar]
  12. Fenwick E. M., Marty A., Neher E. A patch-clamp study of bovine chromaffin cells and of their sensitivity to acetylcholine. J Physiol. 1982 Oct;331:577–597. doi: 10.1113/jphysiol.1982.sp014393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. File S. E. The contribution of behavioural studies to the neuropharmacology of anxiety. Neuropharmacology. 1987 Jul;26(7B):877–886. doi: 10.1016/0028-3908(87)90065-7. [DOI] [PubMed] [Google Scholar]
  14. Foster A. C., Wong E. H. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Br J Pharmacol. 1987 Jun;91(2):403–409. doi: 10.1111/j.1476-5381.1987.tb10295.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gill R., Foster A. C., Woodruff G. N. Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil. J Neurosci. 1987 Oct;7(10):3343–3349. doi: 10.1523/JNEUROSCI.07-10-03343.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gurney A. M., Rang H. P. The channel-blocking action of methonium compounds on rat submandibular ganglion cells. Br J Pharmacol. 1984 Jul;82(3):623–642. doi: 10.1111/j.1476-5381.1984.tb10801.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981 Aug;391(2):85–100. doi: 10.1007/BF00656997. [DOI] [PubMed] [Google Scholar]
  18. Harrison N. L., Simmonds M. A. Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br J Pharmacol. 1985 Feb;84(2):381–391. doi: 10.1111/j.1476-5381.1985.tb12922.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Honey C. R., Miljkovic Z., MacDonald J. F. Ketamine and phencyclidine cause a voltage-dependent block of responses to L-aspartic acid. Neurosci Lett. 1985 Oct 24;61(1-2):135–139. doi: 10.1016/0304-3940(85)90414-8. [DOI] [PubMed] [Google Scholar]
  20. Huettner J. E., Baughman R. W. Primary culture of identified neurons from the visual cortex of postnatal rats. J Neurosci. 1986 Oct;6(10):3044–3060. doi: 10.1523/JNEUROSCI.06-10-03044.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Huettner J. E., Bean B. P. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1307–1311. doi: 10.1073/pnas.85.4.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Johnson J. W., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 1987 Feb 5;325(6104):529–531. doi: 10.1038/325529a0. [DOI] [PubMed] [Google Scholar]
  23. Jones B. J., Costall B., Domeney A. M., Kelly M. E., Naylor R. J., Oakley N. R., Tyers M. B. The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist. Br J Pharmacol. 1988 Apr;93(4):985–993. doi: 10.1111/j.1476-5381.1988.tb11489.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kushner L., Lerma J., Zukin R. S., Bennett M. V. Coexpression of N-methyl-D-aspartate and phencyclidine receptors in Xenopus oocytes injected with rat brain mRNA. Proc Natl Acad Sci U S A. 1988 May;85(9):3250–3254. doi: 10.1073/pnas.85.9.3250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lambert J. J., Durant N. N., Henderson E. G. Drug-induced modification of ionic conductance at the neuromuscular junction. Annu Rev Pharmacol Toxicol. 1983;23:505–539. doi: 10.1146/annurev.pa.23.040183.002445. [DOI] [PubMed] [Google Scholar]
  26. Lingle C. Blockade of cholinergic channels by chlorisondamine on a crustacean muscle. J Physiol. 1983 Jun;339:395–417. doi: 10.1113/jphysiol.1983.sp014723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. MacDonald J. F., Miljkovic Z., Pennefather P. Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine. J Neurophysiol. 1987 Aug;58(2):251–266. doi: 10.1152/jn.1987.58.2.251. [DOI] [PubMed] [Google Scholar]
  28. Maleque M. A., Warnick J. E., Albuquerque E. X. The mechanism and site of action of ketamine on skeletal muscle. J Pharmacol Exp Ther. 1981 Dec;219(3):638–645. [PubMed] [Google Scholar]
  29. Martin D., Lodge D. Ketamine acts as a non-competitive N-methyl-D-aspartate antagonist on frog spinal cord in vitro. Neuropharmacology. 1985 Oct;24(10):999–1003. doi: 10.1016/0028-3908(85)90128-5. [DOI] [PubMed] [Google Scholar]
  30. Martin I. L. The benzodiazepines and their receptors: 25 years of progress. Neuropharmacology. 1987 Jul;26(7B):957–970. doi: 10.1016/0028-3908(87)90074-8. [DOI] [PubMed] [Google Scholar]
  31. Mayer M. L., Westbrook G. L. The action of N-methyl-D-aspartic acid on mouse spinal neurones in culture. J Physiol. 1985 Apr;361:65–90. doi: 10.1113/jphysiol.1985.sp015633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Meldrum B. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin Sci (Lond) 1985 Feb;68(2):113–122. doi: 10.1042/cs0680113. [DOI] [PubMed] [Google Scholar]
  33. Monaghan D. T., Cotman C. W. Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain. J Neurosci. 1985 Nov;5(11):2909–2919. doi: 10.1523/JNEUROSCI.05-11-02909.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Neijt H. C., te Duits I. J., Vijverberg H. P. Pharmacological characterization of serotonin 5-HT3 receptor-mediated electrical response in cultured mouse neuroblastoma cells. Neuropharmacology. 1988 Mar;27(3):301–307. doi: 10.1016/0028-3908(88)90048-2. [DOI] [PubMed] [Google Scholar]
  35. Nowak L., Bregestovski P., Ascher P., Herbet A., Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature. 1984 Feb 2;307(5950):462–465. doi: 10.1038/307462a0. [DOI] [PubMed] [Google Scholar]
  36. Peters J. A., Hales T. G., Lambert J. J. Divalent cations modulate 5-HT3 receptor-induced currents in N1E-115 neuroblastoma cells. Eur J Pharmacol. 1988 Jul 14;151(3):491–495. doi: 10.1016/0014-2999(88)90550-x. [DOI] [PubMed] [Google Scholar]
  37. Peters J. A., Kirkness E. F., Callachan H., Lambert J. J., Turner A. J. Modulation of the GABAA receptor by depressant barbiturates and pregnane steroids. Br J Pharmacol. 1988 Aug;94(4):1257–1269. doi: 10.1111/j.1476-5381.1988.tb11646.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Volle R. L., Alkadhi K. A., Branisteanu D. D., Reynolds L. S., Epstein P. M., Smilowitz H., Lambert J. J., Henderson E. G. Ketamine and ditran block end-plate ion conductance and [3H]phencyclidine binding to electric organ membrane. J Pharmacol Exp Ther. 1982 Jun;221(3):570–576. [PubMed] [Google Scholar]
  39. WILSON H. T. H. Tropical eosinophilia in East Africa. Br Med J. 1947 Jun 7;1(4509):801–804. doi: 10.1136/bmj.1.4509.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. White H. S., Bender A. S., Swinyard E. A. Effect of the selective N-methyl-D-aspartate receptor agonist 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid on [3H]flunitrazepam binding. Eur J Pharmacol. 1988 Feb 16;147(1):149–151. doi: 10.1016/0014-2999(88)90646-2. [DOI] [PubMed] [Google Scholar]
  41. Wong E. H., Kemp J. A., Priestley T., Knight A. R., Woodruff G. N., Iversen L. L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7104–7108. doi: 10.1073/pnas.83.18.7104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wong E. H., Knight A. R., Ransom R. Glycine modulates [3H]MK-801 binding to the NMDA receptor in rat brain. Eur J Pharmacol. 1987 Oct 27;142(3):487–488. doi: 10.1016/0014-2999(87)90095-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES